Statement
MHS team at work

About Us

Welcome to The Microhaem Scientifics

Quality Saves Lives

Fastest emerging IVD Manufacturer

Established in 2012, MHS is the first indigenous IVD test Kits manufacturer in the Great Lakes Region of Africa and one of the leading medical supplies company strategically located in Kampala, Uganda. The company's manufacturing portfolio includes Point of Care tests, Molecular Diagnostics tests and Research and development in the neglected tropical diseases.

Our Mission

MHS has successfully commercialised the high quality products for HIV, Malaria, Sickle Cell and other critical high-burden diseases in Africa.

Our mission is a commitment to the health and well-being of our community and we are here to make a difference.

A parent and child, representing the communities MHS serves

Our Values

We ensure consistent, dependable quality by strictly adhering to international regulatory standards such as ISO and cGMP, while continuously applying industry best practices throughout every stage of our manufacturing and supply process

We align our processes, people, and products to anticipate customer needs, ensuring satisfaction at every point of contact

We hold ourselves to consistent ethical standards, so partners and patients can rely on what we say and what we deliver.

Every batch follows GMP-compliant processes, checked against international best practice at each stage of production.

We work cross-functionally and hold each other accountable to shared, measurable goals.

Our team brings deep expertise across diagnostics manufacturing, regulatory affairs, and quality assurance.

Our Journey

2012
MHS Establishment
Established MHS Logistics Division

In 2012, MHS was founded in Kampala as the first indigenous manufacturer of IVD test kits in the Great Lakes Region, laying the logistics and distribution foundation the company still builds on today.

2015
Rwanda Expansion
Expanded and established the MHS Rwanda

Building on early momentum, MHS extended its footprint into Rwanda, establishing a dedicated presence to supply high-quality medical products across the wider East African region.

2020
Laboratory Services
Established MHL – Test and Fly

MHS launched Test & Fly, its laboratory services division, bringing point-of-care and reference testing capacity closer to the communities that rely on fast, accurate diagnostics.

2022
Vaccine Access
Established Vaccine Access Initiative

Through the Vaccine Access Initiative, MHS began working to close gaps in immunisation access, partnering with regional health systems to strengthen vaccine delivery and cold-chain readiness.

2023
MHS Manufacturing
Vaccination and Vaccines Manufacturing

Following years of investment and innovation, MHS commissioned its manufacturing facility and secured key regulatory approvals, paving the way for large-scale production and positioning Uganda among Africa's emerging health manufacturing hubs.

2025
Expansion
Lorem ipsum dolor sit amet

As MHS advances toward WHO prequalification and global procurement pathways, the company is positioning itself to expand beyond domestic and regional markets and deliver African-made diagnostic solutions to the world.

WhatsApp X